Skip to content
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
BioTechGrid

BioTechGrid

  • Home
  • Biotechnology
  • Medical Technology
  • Research
  • Genetics
  • Press Releases
    • Business Wire
    • GlobeNewswire
    • PRNewswire
  • Contact
Posted inBiotechnology

New intelligence tracks solid-state batteries across their entire life cycle

August 4, 2026
Continue Reading
new-intelligence-tracks-solid-state-batteries-across-their-entire-life-cycle
Posted inBiotechnology

AKR1B10 Serum Marker Aids Liver Cancer Diagnosis and Postoperative Monitoring

August 4, 2026
Continue Reading
akr1b10-serum-marker-aids-liver-cancer-diagnosis-and-postoperative-monitoring
Posted inBiotechnology

How Cytokine Signals from the Immune System Disrupt Brain Circuits

August 4, 2026
Continue Reading
how-cytokine-signals-from-the-immune-system-disrupt-brain-circuits
Posted inBiotechnology

Cambridge scientist unveils Medicine 4.0 framework promoting wider access to ideas, services

August 4, 2026
Continue Reading
cambridge-scientist-unveils-medicine-4.0-framework-promoting-wider-access-to-ideas,-services
Posted inBiotechnology

USC Receives $3.2 Million NIH Grant to Study Age-Related Inflammation and Cancer

August 4, 2026
Continue Reading
usc-receives-$3.2-million-nih-grant-to-study-age-related-inflammation-and-cancer
Posted inBiotechnology

UI Health Ophthalmology Program Named Among Nation’s Best by U.S. News

August 4, 2026
Continue Reading
ui-health-ophthalmology-program-named-among-nation’s-best-by-us.-news
Most Popular Post
exploring-the-future-of-healthcare with-panos-karelis
Posted inArtificial intelligence

Exploring the Future of Healthcare with Panos Karelis

exploring-the-future-of-healthcare with-gordon-wishart,-check4cancer
Posted inArtificial intelligence

Exploring the Future of Healthcare with Gordon Wishart, Check4Cancer

exploring-the-future-of-healthcare with-noam-shomron,-tel-aviv-university
Posted inArtificial intelligence

Exploring the Future of Healthcare with Noam Shomron, Tel Aviv University

exploring-the-future-of-healthcare with-raul-villamarin-rodriguez,-woxsen-university
Posted inArtificial intelligence

Exploring the Future of Healthcare with Raul Villamarin Rodriguez, Woxsen University

merck-kgaa’s-milliporesigma-absorbs-dutch-organoid-maker-hub-organoids
Posted inResearch

Merck KGaA’s MilliporeSigma absorbs Dutch organoid maker HUB Organoids

December 18, 2024
Through its U.S. and Canada life science business MilliporeSigma, Merck KGaA is acquiring Dutch company HUB Organoids. The deal is…
Read More
ring-therapeutics-lays-off-just-under-half-of-staff-in-2nd-wave-of-cuts-this-year,-ceo-set-to-step-down
Posted inBiotechnology

Ring Therapeutics lays off just under half of staff in 2nd wave of cuts this year, CEO set to step down

December 18, 2024
Ring Therapeutics, a Flagship Pioneering-backed biotech developing new viral vectors for gene therapy delivery, has cut its staff by just…
Read More
spatial-transcriptomic-clocks-reveal-local-cellular-interactions-influence-brain-aging
Posted inGenetics

Spatial Transcriptomic Clocks Reveal Local Cellular Interactions Influence Brain Aging

December 18, 2024
Certain cells in the brain create a nurturing environment, enhancing the health and resilience of their neighbors, while others promote…
Read More
novartis,-bioage-take-on-age-related-diseases-in-$550m-pact
Posted inBiotechnology

Novartis, BioAge take on age-related diseases in $550M pact

December 18, 2024
Freshly public BioAge Labs has secured a multi-year partnership with Novartis that focuses on age-related diseases and includes the possibility…
Read More
roche-to-bring-mass-spec-to-routine-labs-with-new-cobas-system’s-european-approval
Posted inMedical Technology

Roche to bring mass spec to routine labs with new cobas system’s European approval

December 18, 2024
Roche has begun rolling out a new diagnostics system that aims to bring the gold-standard accuracy of mass spectrometry to…
Read More
fibrosis-focused-tvardi-to-go-public-via-merger-with-cash-strapped-cara
Posted inBiotechnology

Fibrosis-focused Tvardi to go public via merger with cash-strapped Cara

December 18, 2024
Pruritus drug developer Cara Therapeutics kicked off the year halving its headcount, and the biotech has now found a new…
Read More
merck-&-co.-boosts-glp-1-portfolio-by-paying-$112m-upfront-for-hansoh’s-preclinical-drug
Posted inBiotechnology

Merck & Co. boosts GLP-1 portfolio by paying $112M upfront for Hansoh’s preclinical drug

December 18, 2024
Merck & Co. has added a second GLP-1 candidate to its pipeline, paying China’s Hansoh Pharma $112 million upfront for…
Read More
aurion’s-regenerative-eye-disease-med-improves-vision-in-phase-1/2-trial
Posted inBiotechnology

Aurion’s regenerative eye disease med improves vision in phase 1/2 trial

December 18, 2024
The highest dose of Aurion Biotech’s cell therapy, the main component of which recently received approval in Japan, has improved…
Read More
cognition’s-phase-2-shimmer-results-finally-allow-dementia-drug-to-shine
Posted inBiotechnology

Cognition’s phase 2 SHIMMER results finally allow dementia drug to shine

December 18, 2024
The failure of Cognition Therapeutics’ Alzheimer’s disease candidate CT1812 in the SHINE trial earlier this year may have rubbed off…
Read More
nvidia’s-venture-arm-raises-stake-in-ai-drug-discoverer-genesis-therapeutics
Posted inGenetics

Nvidia’s Venture Arm Raises Stake in AI Drug Discoverer Genesis Therapeutics

December 18, 2024
Evan Feinberg, PhD, founder and CEO of Genesis Therapeutics In the beginning, Genesis Therapeutics spun out from the Stanford University…
Read More

Posts pagination

Previous page 1 … 2,128 2,129 2,130 2,131 2,132 … 2,139 Next page
You May Have Missed
Posted inMedical Technology

Smith & Nephew cuts 2026 outlook as US knee implant sales slide

Posted inMedical Technology

KKR inks $5.7B deal to take medtech manufacturing giant Integer private

Posted inMedical Technology

Curium strikes up to $8B deal for radiopharma rival Lantheus

Posted inMedical Technology

Labcorp posts higher Q2 earnings on strength of diagnostics, lab services; adjusts full-year guidance

Privacy Policy    Terms

Scroll to Top